Bladder Cancer Trial, Recruiting NCT07514897 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT07514897
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with bladder cancer, or your doctor suspects you may have it
  • You have a non-cancerous urological condition, such as kidney stones, bladder stones, bladder inflammation (cystitis), or a narrowed ureter
  • You are willing to allow your urine and tissue samples to be used for research purposes
  • You are between 18 and 75 years old
  • You are willing to sign a consent form, follow the study rules, and attend any required follow-up appointments

Who may not be able to join:

  • You have been diagnosed with another type of cancer in the past 5 years, or have received any cancer treatment in that time
  • You have bladder cancer alongside another cancer of the urinary or reproductive system, such as kidney cancer or prostate cancer
  • Your samples were not collected or stored in the proper, required way
  • Your medical records or relevant information are incomplete
  • You have difficulty communicating, understanding instructions, or following through with study requirements, making it hard to complete follow-up visits
  • The trial team decides, for any other reason, that participation would not be appropriate for you (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xiongjun Ye, +86 13910380916

Phone: +86 13910380916

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Discrimination of the diagnostic model

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov